HuGE Literature Finder
Records 1-5
|
rs3918242 MMP9 gene polymorphism is associated with myocardial infarction in Mexican patients.
Genetics and molecular research : GMR 2016 15 (1): . Rodríguez-Pérez J M, Vargas-Alarcón G, Posadas-Sánchez R, Zagal-Jiménez T X, Ortíz-Alarcón R, Valente-Acosta B, Tovilla-Zárate C, Nostroza-Hernández C, Pérez-Méndez O, Pérez-Hernández |
|
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.
Pharmacogenetics and genomics 2012 May 22 (5): 355-66. Lynch Amy I, Eckfeldt John H, Davis Barry R, Ford Charles E, Boerwinkle Eric, Leiendecker-Foster Catherine, Arnett Donna |
|
Polymorphisms of matrix metalloproteinases in systolic heart failure: role on disease susceptibility, phenotypic characteristics, and prognosis.
Journal of cardiac failure 2011 Feb 17 (2): 115-21. Velho Fábio M, Cohen Carolina R, Santos Kátia G, Silvello Daiane, Martinelli Nidiane, Biolo Andréia, Clausell Nadine, Rohde Luis |
|
Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
American heart journal 2007 Dec 154 (6): 1043-51. Hlatky Mark A, Ashley Euan, Quertermous Thomas, Boothroyd Derek B, Ridker Paul, Southwick Audrey, Myers Richard M, Iribarren Carlos, Fortmann Stephen P, Go Alan S, |
|
Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction.
Circulation research 2005 Nov 97 (10): 1070-6. Pearce Eve, Tregouet David-Alexandre, Samnegård Ann, Morgan Angharad R, Cox Charles, Hamsten Anders, Eriksson Per, Ye S |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 02, 2021
- Content source: